Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer

Submitted by ktsaganis@resea... on Mon, 02/18/2019 - 14:35

February 14, 2019, San Francisco, California

Please note that slides are for review only and not to be repurposed or published.

Introduction:
Dr Neil Love

MODULE 1:
Incorporation of Androgen Receptor Antagonists into the Management of M0 Prostate Cancer (PC) — Dr Smith

MODULE 2:
Management of Metastatic Hormone-Sensitive PC (mHSPC) — Dr Sternberg

MODULE 3:
Current and Future Management of Metastatic CRPC (mCRPC) — Dr Scher

MODULE 4:
Biologic Rationale for and Ongoing Evaluation of PARP Inhibitors in the Management of mPC — Dr Antonarakis

MODULE 5:
Bone-Targeted Therapies and Other Emerging Radiopharmaceuticals — Dr Sartor

Live Poll Results
Download